comparemela.com

Latest Breaking News On - Adjusted diluted earnings - Page 8 : comparemela.com

Levi Strauss & Co. Reports First-Quarter 2024 Financial Results

Q1 Earnings Results Above Expectations Gross Margin of 58.2% Up 240 BPS Over Prior Year Driven by Lower Product Costs & Favorable Mix Shift Global DTC Up 7% Including 10% Growth in the U.S. Diluted.

Ukraine
Russia
United-states
Harmit-singh
Michelle-gass
Exchange-commission
Levi-strauss-co
Levi-strauss
Chief-financial
Growth-officer
Project-fuel
Beyond-yoga

Lands' End Announces Fourth Quarter and Full Year Fiscal 2023 Results

Lands' End Announces Fourth Quarter and Full Year Fiscal 2023 Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Hong-kong
United-states
Japan
American
Andrew-mclean
Bernie-mccracken
Bernard-mccracken
Tom-filandro
Company-third-party
Lands-end
Third-party-net
Company-annual-report-on-form

Lands' End, Inc.: Lands' End Announces Fourth Quarter and Full Year Fiscal 2023 Results

Lands' End, Inc.: Lands' End Announces Fourth Quarter and Full Year Fiscal 2023 Results
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Japan
Hong-kong
United-states
American
Bernie-mccracken
Tom-filandro
Andrew-mclean
Bernard-mccracken
Dennis-riedl
Nasdaq
Land-end-inc
Delta-air-lines

Amneal Reports Fourth Quarter and Full Year 2023 Financial Results

Amneal Reports Fourth Quarter and Full Year 2023 Financial Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states
America
Chintu-patel
Anthony-dimeo
Saol-international
Drug-administration
Amneal-group
Amneal-pharmaceuticals-inc
Exchange-commission
Kashiv-specialty-pharmaceuticals
Nasdaq
Full-year

vimarsana © 2020. All Rights Reserved.